BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28351596)

  • 1. Brain edema with clasmatodendrosis complicating ataxia telangiectasia.
    Shimoda K; Mimaki M; Fujino S; Takeuchi M; Hino R; Uozaki H; Hayashi M; Oka A; Mizuguchi M
    Brain Dev; 2017 Aug; 39(7):629-632. PubMed ID: 28351596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral abnormalities in adults with ataxia-telangiectasia.
    Lin DD; Barker PB; Lederman HM; Crawford TO
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):119-23. PubMed ID: 23886747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia: diagnosis and treatment.
    Perlman S; Becker-Catania S; Gatti RA
    Semin Pediatr Neurol; 2003 Sep; 10(3):173-82. PubMed ID: 14653405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain MRI abnormalities in ataxia-telangiectasia.
    Habek M; Brinar VV; Rados M; Zadro I; Zarković K
    Neurologist; 2008 May; 14(3):192-5. PubMed ID: 18469676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic dysfunction in patients with Ataxia-Telangiectasia.
    Tubani L; Donato G; Perciaccante A; Baratta L; Fiorentini A; Fiorilli M
    Clin Neurophysiol; 2006 Jul; 117(7):1630-1. PubMed ID: 16753332
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature.
    DeWire MD; Beltran C; Boop FA; Helton KJ; Ellison DW; McKinnon PJ; Gajjar A; Pai Panandiker AS
    J Clin Oncol; 2013 Jan; 31(1):e12-4. PubMed ID: 22689803
    [No Abstract]   [Full Text] [Related]  

  • 7. Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation.
    Pietrucha BM; Heropolitańska-Pliszka E; Wakulińska A; Skopczyńska H; Gatti RA; Bernatowska E
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):e28-30. PubMed ID: 20051774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia-telangiectasia and wilms tumor: reduced treatment but early relapse.
    Pérez-Villena A; Cormenzana M; de Prada I; Pérez-Martínez A; Aleo E
    J Pediatr Hematol Oncol; 2013 May; 35(4):308-10. PubMed ID: 23612382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ataxia telangiectasia model: inefficient cell differentiation and possible reversal by serine protease inhibitors, tumor necrosis factor inhibitors, dexamethasone, and glutathione enhancers.
    Knittweis J
    Med Hypotheses; 1998 Jul; 51(1):53-7. PubMed ID: 9881837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ataxia-telangiectasia: a review].
    Bott L; Thumerelle C; Cuvellier JC; Deschildre A; Vallée L; Sardet A
    Arch Pediatr; 2006 Mar; 13(3):293-8. PubMed ID: 16423518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia.
    Chung EO; Bodensteiner JB; Noorani PA; Schochet SS
    J Child Neurol; 1994 Jan; 9(1):31-5. PubMed ID: 7512106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ataxia telangiectasia. A prototype of neurological involvement in primary immune deficiencies].
    Liptai Z
    Orv Hetil; 2018 Dec; 159(49):2057-2064. PubMed ID: 30525879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology in classical and variant ataxia-telangiectasia.
    Verhagen MM; Martin JJ; van Deuren M; Ceuterick-de Groote C; Weemaes CM; Kremer BH; Taylor MA; Willemsen MA; Lammens M
    Neuropathology; 2012 Jun; 32(3):234-44. PubMed ID: 22017321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered corticomotor-cerebellar integrity in young ataxia telangiectasia patients.
    Sahama I; Sinclair K; Fiori S; Pannek K; Lavin M; Rose S
    Mov Disord; 2014 Sep; 29(10):1289-98. PubMed ID: 25042086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ATM mutations with ataxia-telangiectasia.
    Liu XL; Wang T; Huang XJ; Zhou HY; Luan XH; Shen JY; Chen SD; Cao L
    Neurosci Lett; 2016 Jan; 611():112-5. PubMed ID: 26628246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than ataxia - Movement disorders in ataxia-telangiectasia.
    Teive HAG; Camargo CHF; Munhoz RP
    Parkinsonism Relat Disord; 2018 Jan; 46():3-8. PubMed ID: 29249681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible control of cell death pathways in ataxia telangiectasia. A case report.
    Lynn WS; Wong PK
    Neuroimmunomodulation; 1997; 4(5-6):277-84. PubMed ID: 9650822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegeneration in ataxia telangiectasia: what is new? What is evident?
    Hoche F; Seidel K; Theis M; Vlaho S; Schubert R; Zielen S; Kieslich M
    Neuropediatrics; 2012 Jun; 43(3):119-29. PubMed ID: 22614068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor pathway degeneration in young ataxia telangiectasia patients: A diffusion tractography study.
    Sahama I; Sinclair K; Fiori S; Doecke J; Pannek K; Reid L; Lavin M; Rose S
    Neuroimage Clin; 2015; 9():206-15. PubMed ID: 26413479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity.
    Gosink EC; Chong MJ; McKinnon PJ
    Cancer Res; 1999 Oct; 59(20):5294-8. PubMed ID: 10537312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.